PET imaging in the heart

PET Imaging in Drug Design & development (PET3D)

^{Figure: (a) PET/CT scan of a pre-clinical model’s abdominal region. (b) Logo of the PET3D project.}

Positron Emission Tomography (PET) imaging is most commonly used as a diagnostic technique – radioactive ‘tracer’ molecules are injected into patients and PET is used to observe the functioning of the body and identify signs of abnormalities, including heart conditions. PET3D is a €4million doctoral training scheme – coordinated by the University of Aberdeen - that will tackle a European shortage of scientists who can use PET Imaging for speeding up and reduce the cost of life-saving drug development.

Funded by the European Commission (H2020 Marie Skłodowska-Curie ITN-European Training Network)

• PET3D

Project team:

• Professor Matteo Zanda (Research scientist, University of Aberdeen)
• Dr Sergio Dall’Angelo (Research scientist, University of Aberdeen)